EMT regulation in gastrointestinal epithelial cells View Homepage


Ontology type: schema:MonetaryGrant     


Grant Info

YEARS

1995-2017

FUNDING AMOUNT

4416782 USD

ABSTRACT

DESCRIPTION (provided by applicant): Prevailing experimental evidence suggests that counter-regulatory crosstalk between TGFbeta/BMP/Smad4 and Wnt/beta-catenin signaling pathways is central to normal intestinal homeostasis and that loss of this regulation promotes carcinogenesis, however, the underlying mechanisms of this regulatory crosstalk are incompletely understood. The long-term goal of our laboratory is to delineate the mechanisms that drive colorectal carcinogenesis and tumor progression and to identify improved prognostic biomarkers and novel therapeutic targets in colon cancer. The overall objective of this proposal is to identify specific interactions between Smad4 and Wnt signaling pathways that maintain homeostasis and drive tumor cell behavior in the intestine. Based upon our own work and that from other laboratories, we propose to test the following central hypothesis: loss of Smad4 expression in colon epithelial cells and colon cancer cells amplifies β-catenin expression and Wnt signaling, thereby promoting tumor progression. The rationale underlying the proposed research is based on our observations that Smad4 loss in colonic crypts leads to disruption of intestinal homeostasis and enhanced susceptibility to intestinal tumorigenesis and that silencing of Smad4 in cell lines results in increased beta-catenin expression and increased beta-catenin/TCF activated gene expression. The goal of this proposal is to determine the biological consequences of Smad4 loss in the intestine and to determine the mechanism by which Smad4 loss increases beta-catenin and amplifies Wnt signaling. Specific Aim 1: Determine the impact of intestinal epithelial cell loss of Smad4 signaling on Wnt signaling, homeostasis and barrier function in the mouse intestinal tract. Working hypothesis: Smad4 regulation of beta-catenin mRNA expression in the intestinal tract is required for homeostasis and barrier function in the intestinal tract. We will use innovative mouse models with inducible tissue specific depletion of Smad4 to test this working hypothesis. Specific Aim 2: Determine the mechanism of Smad4-mediated regulation of beta-catenin mRNA expression and beta-catenin activated gene expression. Working Hypothesis: The tumor suppressive activity of Smad4 occurs through repression of ß-catenin expression and inhibition of the beta-catenin dependent transcriptional program. In this aim, we will determine the mechanisms by which Smad4 mediated signaling impacts beta-catenin expression and Wnt/ß-catenin activated gene expression. This proposal has high impact because it fills significant gaps in understanding of how an important tumor suppressor and proto-oncogene interact to achieve homeostasis in the normal intestinal epithelium, and how disruption of this normal regulation leads to metastasis and mortality in cancer. Through these insights, we expect to identify novel targets for therapeutic intervention. More... »

URL

http://projectreporter.nih.gov/project_info_description.cfm?aid=9248571

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2206", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "amount": {
      "currency": "USD", 
      "type": "MonetaryAmount", 
      "value": "4416782"
    }, 
    "description": "DESCRIPTION (provided by applicant): Prevailing experimental evidence suggests that counter-regulatory crosstalk between TGFbeta/BMP/Smad4 and Wnt/beta-catenin signaling pathways is central to normal intestinal homeostasis and that loss of this regulation promotes carcinogenesis, however, the underlying mechanisms of this regulatory crosstalk are incompletely understood. The long-term goal of our laboratory is to delineate the mechanisms that drive colorectal carcinogenesis and tumor progression and to identify improved prognostic biomarkers and novel therapeutic targets in colon cancer. The overall objective of this proposal is to identify specific interactions between Smad4 and Wnt signaling pathways that maintain homeostasis and drive tumor cell behavior in the intestine. Based upon our own work and that from other laboratories, we propose to test the following central hypothesis: loss of Smad4 expression in colon epithelial cells and colon cancer cells amplifies β-catenin expression and Wnt signaling, thereby promoting tumor progression. The rationale underlying the proposed research is based on our observations that Smad4 loss in colonic crypts leads to disruption of intestinal homeostasis and enhanced susceptibility to intestinal tumorigenesis and that silencing of Smad4 in cell lines results in increased beta-catenin expression and increased beta-catenin/TCF activated gene expression. The goal of this proposal is to determine the biological consequences of Smad4 loss in the intestine and to determine the mechanism by which Smad4 loss increases beta-catenin and amplifies Wnt signaling. Specific Aim 1: Determine the impact of intestinal epithelial cell loss of Smad4 signaling on Wnt signaling, homeostasis and barrier function in the mouse intestinal tract. Working hypothesis: Smad4 regulation of beta-catenin mRNA expression in the intestinal tract is required for homeostasis and barrier function in the intestinal tract. We will use innovative mouse models with inducible tissue specific depletion of Smad4 to test this working hypothesis. Specific Aim 2: Determine the mechanism of Smad4-mediated regulation of beta-catenin mRNA expression and beta-catenin activated gene expression. Working Hypothesis: The tumor suppressive activity of Smad4 occurs through repression of \u00df-catenin expression and inhibition of the beta-catenin dependent transcriptional program. In this aim, we will determine the mechanisms by which Smad4 mediated signaling impacts beta-catenin expression and Wnt/\u00df-catenin activated gene expression. This proposal has high impact because it fills significant gaps in understanding of how an important tumor suppressor and proto-oncogene interact to achieve homeostasis in the normal intestinal epithelium, and how disruption of this normal regulation leads to metastasis and mortality in cancer. Through these insights, we expect to identify novel targets for therapeutic intervention.", 
    "endDate": "2017-05-31T00:00:00Z", 
    "funder": {
      "id": "https://www.grid.ac/institutes/grid.48336.3a", 
      "type": "Organization"
    }, 
    "id": "sg:grant.2472568", 
    "identifier": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "2472568"
        ]
      }, 
      {
        "name": "nih_id", 
        "type": "PropertyValue", 
        "value": [
          "R01CA069457"
        ]
      }
    ], 
    "inLanguage": [
      "en"
    ], 
    "keywords": [
      "applicants", 
      "inducible tissue", 
      "intestinal epithelial cell loss", 
      "susceptibility", 
      "intestine", 
      "mechanism", 
      "therapeutic intervention", 
      "colorectal carcinogenesis", 
      "observations", 
      "impact", 
      "colon cancer cells", 
      "disruption", 
      "hypothesis", 
      "experimental evidence", 
      "significant gaps", 
      "intestinal tumorigenesis", 
      "Wnt/beta-catenin", 
      "catenin expression", 
      "underlying mechanisms", 
      "Smad4 expression", 
      "cell lines results", 
      "proto-oncogene interact", 
      "working hypothesis", 
      "epithelial cells", 
      "prognostic biomarker", 
      "normal intestinal epithelium", 
      "catenin", 
      "novel therapeutic targets", 
      "TGFbeta/BMP/Smad4", 
      "inhibition", 
      "Specific Aim 1", 
      "understanding", 
      "intestinal homeostasis", 
      "Specific Aim 2", 
      "tumor", 
      "dependent transcriptional program", 
      "specific depletion", 
      "mortality", 
      "homeostasis", 
      "description", 
      "SMAD4 loss", 
      "rationale", 
      "intestinal tract", 
      "Wnt/\u00df", 
      "long-term goal", 
      "EMT regulation", 
      "aim", 
      "research", 
      "high impact", 
      "normal regulation", 
      "overall objective", 
      "own work", 
      "carcinogenesis", 
      "mice", 
      "loss", 
      "regulation", 
      "pathway", 
      "Smad4", 
      "goal", 
      "gene expression", 
      "repression", 
      "gastrointestinal epithelial cells", 
      "regulatory crosstalk", 
      "normal intestinal homeostasis", 
      "impacts beta-catenin expression", 
      "other laboratories", 
      "beta-catenin", 
      "metastasis", 
      "expression", 
      "tumor progression", 
      "specific interactions", 
      "colon cancer", 
      "laboratory", 
      "Wnt", 
      "barrier function", 
      "tumor cell behavior", 
      "Smad4-mediated regulation", 
      "biological consequences", 
      "counter-regulatory crosstalk", 
      "cancer", 
      "colon", 
      "central hypothesis", 
      "Smad4 regulation", 
      "proposal", 
      "important tumor suppressor", 
      "beta-catenin expression", 
      "TCF", 
      "innovative mouse models", 
      "suppressive activity", 
      "insight", 
      "novel target", 
      "beta-catenin mRNA expression", 
      "colonic crypts"
    ], 
    "name": "EMT regulation in gastrointestinal epithelial cells", 
    "recipient": [
      {
        "id": "https://www.grid.ac/institutes/grid.412807.8", 
        "type": "Organization"
      }, 
      {
        "affiliation": {
          "id": "https://www.grid.ac/institutes/grid.412807.8", 
          "name": "VANDERBILT UNIVERSITY MEDICAL CENTER", 
          "type": "Organization"
        }, 
        "familyName": "BEAUCHAMP", 
        "givenName": "ROBERT DANIEL", 
        "id": "sg:person.01355254152.34", 
        "type": "Person"
      }, 
      {
        "member": "sg:person.01355254152.34", 
        "roleName": "PI", 
        "type": "Role"
      }
    ], 
    "sameAs": [
      "https://app.dimensions.ai/details/grant/grant.2472568"
    ], 
    "sdDataset": "grants", 
    "sdDatePublished": "2019-03-07T12:13", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com.uberresearch.data.processor/core_data/20181219_192338/projects/base/nih_projects_6.xml.gz", 
    "startDate": "1995-06-15T00:00:00Z", 
    "type": "MonetaryGrant", 
    "url": "http://projectreporter.nih.gov/project_info_description.cfm?aid=9248571"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/grant.2472568'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/grant.2472568'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/grant.2472568'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/grant.2472568'


 

This table displays all metadata directly associated to this object as RDF triples.

137 TRIPLES      19 PREDICATES      115 URIs      107 LITERALS      5 BLANK NODES

Subject Predicate Object
1 sg:grant.2472568 schema:about anzsrc-for:2206
2 schema:amount N4a480c0e33b74501bdfff1bcca0ad29a
3 schema:description DESCRIPTION (provided by applicant): Prevailing experimental evidence suggests that counter-regulatory crosstalk between TGFbeta/BMP/Smad4 and Wnt/beta-catenin signaling pathways is central to normal intestinal homeostasis and that loss of this regulation promotes carcinogenesis, however, the underlying mechanisms of this regulatory crosstalk are incompletely understood. The long-term goal of our laboratory is to delineate the mechanisms that drive colorectal carcinogenesis and tumor progression and to identify improved prognostic biomarkers and novel therapeutic targets in colon cancer. The overall objective of this proposal is to identify specific interactions between Smad4 and Wnt signaling pathways that maintain homeostasis and drive tumor cell behavior in the intestine. Based upon our own work and that from other laboratories, we propose to test the following central hypothesis: loss of Smad4 expression in colon epithelial cells and colon cancer cells amplifies β-catenin expression and Wnt signaling, thereby promoting tumor progression. The rationale underlying the proposed research is based on our observations that Smad4 loss in colonic crypts leads to disruption of intestinal homeostasis and enhanced susceptibility to intestinal tumorigenesis and that silencing of Smad4 in cell lines results in increased beta-catenin expression and increased beta-catenin/TCF activated gene expression. The goal of this proposal is to determine the biological consequences of Smad4 loss in the intestine and to determine the mechanism by which Smad4 loss increases beta-catenin and amplifies Wnt signaling. Specific Aim 1: Determine the impact of intestinal epithelial cell loss of Smad4 signaling on Wnt signaling, homeostasis and barrier function in the mouse intestinal tract. Working hypothesis: Smad4 regulation of beta-catenin mRNA expression in the intestinal tract is required for homeostasis and barrier function in the intestinal tract. We will use innovative mouse models with inducible tissue specific depletion of Smad4 to test this working hypothesis. Specific Aim 2: Determine the mechanism of Smad4-mediated regulation of beta-catenin mRNA expression and beta-catenin activated gene expression. Working Hypothesis: The tumor suppressive activity of Smad4 occurs through repression of ß-catenin expression and inhibition of the beta-catenin dependent transcriptional program. In this aim, we will determine the mechanisms by which Smad4 mediated signaling impacts beta-catenin expression and Wnt/ß-catenin activated gene expression. This proposal has high impact because it fills significant gaps in understanding of how an important tumor suppressor and proto-oncogene interact to achieve homeostasis in the normal intestinal epithelium, and how disruption of this normal regulation leads to metastasis and mortality in cancer. Through these insights, we expect to identify novel targets for therapeutic intervention.
4 schema:endDate 2017-05-31T00:00:00Z
5 schema:funder https://www.grid.ac/institutes/grid.48336.3a
6 schema:identifier N0fa55e4a13db463b9d8538248247d353
7 Nf92e7344718a49069d0b4675703ad683
8 schema:inLanguage en
9 schema:keywords EMT regulation
10 SMAD4 loss
11 Smad4
12 Smad4 expression
13 Smad4 regulation
14 Smad4-mediated regulation
15 Specific Aim 1
16 Specific Aim 2
17 TCF
18 TGFbeta/BMP/Smad4
19 Wnt
20 Wnt/beta-catenin
21 Wnt/ß
22 aim
23 applicants
24 barrier function
25 beta-catenin
26 beta-catenin expression
27 beta-catenin mRNA expression
28 biological consequences
29 cancer
30 carcinogenesis
31 catenin
32 catenin expression
33 cell lines results
34 central hypothesis
35 colon
36 colon cancer
37 colon cancer cells
38 colonic crypts
39 colorectal carcinogenesis
40 counter-regulatory crosstalk
41 dependent transcriptional program
42 description
43 disruption
44 epithelial cells
45 experimental evidence
46 expression
47 gastrointestinal epithelial cells
48 gene expression
49 goal
50 high impact
51 homeostasis
52 hypothesis
53 impact
54 impacts beta-catenin expression
55 important tumor suppressor
56 inducible tissue
57 inhibition
58 innovative mouse models
59 insight
60 intestinal epithelial cell loss
61 intestinal homeostasis
62 intestinal tract
63 intestinal tumorigenesis
64 intestine
65 laboratory
66 long-term goal
67 loss
68 mechanism
69 metastasis
70 mice
71 mortality
72 normal intestinal epithelium
73 normal intestinal homeostasis
74 normal regulation
75 novel target
76 novel therapeutic targets
77 observations
78 other laboratories
79 overall objective
80 own work
81 pathway
82 prognostic biomarker
83 proposal
84 proto-oncogene interact
85 rationale
86 regulation
87 regulatory crosstalk
88 repression
89 research
90 significant gaps
91 specific depletion
92 specific interactions
93 suppressive activity
94 susceptibility
95 therapeutic intervention
96 tumor
97 tumor cell behavior
98 tumor progression
99 underlying mechanisms
100 understanding
101 working hypothesis
102 schema:name EMT regulation in gastrointestinal epithelial cells
103 schema:recipient Na0739c3f6b4149529cfc7280faa72f1f
104 sg:person.01355254152.34
105 https://www.grid.ac/institutes/grid.412807.8
106 schema:sameAs https://app.dimensions.ai/details/grant/grant.2472568
107 schema:sdDatePublished 2019-03-07T12:13
108 schema:sdLicense https://scigraph.springernature.com/explorer/license/
109 schema:sdPublisher N8dcdd3a7e223418084088e81662c143b
110 schema:startDate 1995-06-15T00:00:00Z
111 schema:url http://projectreporter.nih.gov/project_info_description.cfm?aid=9248571
112 sgo:license sg:explorer/license/
113 sgo:sdDataset grants
114 rdf:type schema:MonetaryGrant
115 N0fa55e4a13db463b9d8538248247d353 schema:name dimensions_id
116 schema:value 2472568
117 rdf:type schema:PropertyValue
118 N4a480c0e33b74501bdfff1bcca0ad29a schema:currency USD
119 schema:value 4416782
120 rdf:type schema:MonetaryAmount
121 N8dcdd3a7e223418084088e81662c143b schema:name Springer Nature - SN SciGraph project
122 rdf:type schema:Organization
123 Na0739c3f6b4149529cfc7280faa72f1f schema:member sg:person.01355254152.34
124 schema:roleName PI
125 rdf:type schema:Role
126 Nf92e7344718a49069d0b4675703ad683 schema:name nih_id
127 schema:value R01CA069457
128 rdf:type schema:PropertyValue
129 anzsrc-for:2206 schema:inDefinedTermSet anzsrc-for:
130 rdf:type schema:DefinedTerm
131 sg:person.01355254152.34 schema:affiliation https://www.grid.ac/institutes/grid.412807.8
132 schema:familyName BEAUCHAMP
133 schema:givenName ROBERT DANIEL
134 rdf:type schema:Person
135 https://www.grid.ac/institutes/grid.412807.8 schema:name VANDERBILT UNIVERSITY MEDICAL CENTER
136 rdf:type schema:Organization
137 https://www.grid.ac/institutes/grid.48336.3a schema:Organization
 




Preview window. Press ESC to close (or click here)


...